178 related articles for article (PubMed ID: 23982363)
21. Choices of incidental findings of individuals undergoing genome wide sequencing, a single center's experience.
Bishop CL; Strong KA; Dimmock DP
Clin Genet; 2017 Jan; 91(1):137-140. PubMed ID: 27392285
[TBL] [Abstract][Full Text] [Related]
22. Point-counterpoint. Ethics and genomic incidental findings.
McGuire AL; Joffe S; Koenig BA; Biesecker BB; McCullough LB; Blumenthal-Barby JS; Caulfield T; Terry SF; Green RC
Science; 2013 May; 340(6136):1047-8. PubMed ID: 23686340
[No Abstract] [Full Text] [Related]
23. The Ethics of Delivering Precision Medicine-Pretest Counseling and Somatic Genomic Testing.
Borno HT; Rider JR; Gunn CM
JAMA Oncol; 2020 Jun; 6(6):815-816. PubMed ID: 32163096
[No Abstract] [Full Text] [Related]
24. Genetic Counselors' Experience with and Opinions on the Management of Newborn Screening Incidental Carrier Findings.
Leppert K; Bisordi K; Nieto J; Maloney K; Guan Y; Dixon S; Egense A
J Genet Couns; 2018 Dec; 27(6):1328-1340. PubMed ID: 29687313
[TBL] [Abstract][Full Text] [Related]
25. Genetics: Fluent in DNA.
Eisenstein M
Nature; 2015 Oct; 526(7571):151-2. PubMed ID: 26443869
[No Abstract] [Full Text] [Related]
26. Genetic testing in assisted reproduction.
Fruchtman CE; Lieber C
Hastings Cent Rep; 2003; 33(6):11; discussion 11-2. PubMed ID: 14983553
[No Abstract] [Full Text] [Related]
27. Next-generation DNA sequencing: implications for oncology care.
Mahon SM
Oncol Nurs Forum; 2013 Sep; 40(5):437-9. PubMed ID: 23989017
[No Abstract] [Full Text] [Related]
28. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
[TBL] [Abstract][Full Text] [Related]
29. Attitudes toward the right to autonomous decision-making in psychiatric genetic testing: Controversial and context-dependent.
Strohmaier J; Witt SH; Frank J; Lemme N; Flatau L; Streit F; Foo JC; Reitt M; Rujescu D; Schulze TG; Lanzerath D; Illes F; Degenhardt F; Rietschel M
Am J Med Genet B Neuropsychiatr Genet; 2019 Dec; 180(8):555-565. PubMed ID: 30912305
[TBL] [Abstract][Full Text] [Related]
30. Incidentalome from Genomic Sequencing: A Barrier to Personalized Medicine?
Jamuar SS; Kuan JL; Brett M; Tiang Z; Tan WL; Lim JY; Liew WK; Javed A; Liew WK; Law HY; Tan ES; Lai A; Ng I; Teo YY; Venkatesh B; Reversade B; Tan EC; Foo R
EBioMedicine; 2016 Mar; 5():211-6. PubMed ID: 27077130
[TBL] [Abstract][Full Text] [Related]
31. Re-contact to advise of testing available to detect high risk for carcinoma: response to letters sent to persons initially ascertained for other genetic reasons.
Swiglo BA; Lebel RR
Am J Hum Genet; 1997 Oct; 61(4):A390. PubMed ID: 11644970
[No Abstract] [Full Text] [Related]
32. Cases in Precision Medicine: The Role of Tumor and Germline Genetic Testing in Breast Cancer Management.
Tischler J; Crew KD; Chung WK
Ann Intern Med; 2019 Dec; 171(12):925-930. PubMed ID: 31634909
[TBL] [Abstract][Full Text] [Related]
33. Adolescents' preferences regarding disclosure of incidental findings in genomic sequencing that are not medically actionable in childhood.
Hufnagel SB; Martin LJ; Cassedy A; Hopkin RJ; Antommaria AH
Am J Med Genet A; 2016 Aug; 170(8):2083-8. PubMed ID: 27149544
[TBL] [Abstract][Full Text] [Related]
34. [AP-PCR genomic fingerprinting].
Kohno T; Yokota J
Tanpakushitsu Kakusan Koso; 1996 Apr; 41(5):629-32. PubMed ID: 8650354
[No Abstract] [Full Text] [Related]
35. Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations.
Katz SJ; Kurian AW; Morrow M
JAMA; 2015 Sep; 314(10):997-8. PubMed ID: 26203642
[No Abstract] [Full Text] [Related]
36. Ethical signposts for clinical geneticists in secondary variant and incidental finding disclosure discussions.
Christenhusz GM; Devriendt K; Van Esch H; Dierickx K
Med Health Care Philos; 2015 Aug; 18(3):361-70. PubMed ID: 25407129
[TBL] [Abstract][Full Text] [Related]
37. Ethics and genomic medicine, how to navigate decisions in surgical oncology.
Devon KM; Lerner-Ellis JP; Ganai S; Angelos P
J Surg Oncol; 2015 Jan; 111(1):18-23. PubMed ID: 25183289
[TBL] [Abstract][Full Text] [Related]
38. Integrated patient and tumor genetic testing for individualized cancer therapy.
Hertz DL; McLeod HL
Clin Pharmacol Ther; 2016 Feb; 99(2):143-6. PubMed ID: 26537014
[TBL] [Abstract][Full Text] [Related]
39. Managing the ethical challenges of next-generation sequencing in genomic medicine.
Clarke AJ
Br Med Bull; 2014 Sep; 111(1):17-30. PubMed ID: 25122627
[TBL] [Abstract][Full Text] [Related]
40. Direct-to-consumer personal genome testing and cancer risk prediction.
Bellcross CA; Page PZ; Meaney-Delman D
Cancer J; 2012; 18(4):293-302. PubMed ID: 22846729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
